Antibody Drug Conjugate Market : Latest Innovations, Drivers, Scope and Industry Key Events

The global antibody drug conjugate market is likely to grow at a 19% CAGR between 2017- 2023, reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, multiple myeloma, breast cancer, solid tumors, skin cancer, ovary cancer, colon cancer, lung cancer, glioblastoma, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others are some of its key applications. The different antibody drug conjugates include drug/toxin, linker, and monoclonal antibodies, to name a few. 

 Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research.  

On the contrary, shortage of funds & high procedure prices are factors that are likely to impede the global antibody drug conjugate market growth during the forecast period. 

 Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/1113

 Market Segmentation

The MRFR report provides an inclusive segmental analysis of the antibody drug conjugate market by end user, application, technology, product, and type. 

 Based on type, the antibody drug conjugate market has been segmented into drug/toxin, linker, monoclonal antibodies, & other types. 

 Based on application, the market for antibody drug conjugate has been segmented into solid tumors, skin, lymphoma, multiple myeloma, cancer, colon cancer, lung cancer, glioblastoma, ovary cancer, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others. The leukemia segment is again segmented into chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and others. 

 By product, the antibody drug conjugate market has been segmented into adcertis, kadcyla, & other products. 

 By technology, the global antibody drug conjugate market has been segmented into ImmunoGen technology, immunomedics technology, Seattle genetics technology, and others. 

 By end user, the antibody drug conjugate market is segmented into biopharmaceutical companies, biotechnology companies, academic research institutes, specialized cancer centers, hospitals, and others. 

 Regional Analysis

 Based on the region, the global antibody drug conjugate market covers the recent trends and growth opportunities across Europe, the Asia Pacific (APAC), the Americas, and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for increasing healthcare awareness and rising prevalence of cancer. 

 The antibody drug conjugate market in Europe is predicted to have healthy growth over the forecast period for the huge population being affected by cancer. Besides, the government is focussing on R&D to develop new drugs to offer citizens the best treatment. 

 The antibody drug conjugate market in the APAC region is predicted to grow at a fast rate over the forecast period due to increasing prevalence of cancer in India & China. 

 The antibody drug conjugate market in the MEA is predicted to have steady growth over the forecast period. 

 Competitive Analysis

Leading antibody drug conjugate companies profiled in the global antibody drug conjugate market report include Vaccinex Inc (U.S.), Antikor (U.K), Agensys, Inc. (U.S.), Concortis Biotherapeutics (U.S.), Genentech (U.S.), Roche Holding AG (Switzerland), ImmunoGen, Inc.(U.S.), and Seattle Genetics (U.S.). Industry players have implemented different strategies such as acquisitions, mergers, extensive R&D, joint ventures, partnerships, strategic alliances, and new product launches to stay ahead in the competition and also cater to the growing needs of the customers. 

 Browse Table of Content with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market-1113

 

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com


Comments

Post a Comment

Popular posts from this blog

Immunotherapy Drugs market Size Witness A Considerable CAGR Growth Through The Forecast Period

  Recently added new market study, titled “Immunotherapy Drugs market Research Report - Forecast to 2023” by Market Research Future (MRFR) Therapies like chemotherapy and other radiotherapy is not effective in melanoma cancer. Immunotherapies show a better result for the treatment of melanoma cancer. Immunotherapies are used for limited number of cancer treatment mostly hematological, but they show better results where other therapy is not effective. Increasing cancer population, increasing healthcare expenditure with rising government support for research & development are the major driving factor for the market. Majority of manufacturers are actively working in research & development of immunotherapy drugs because of huge necessities like better treatment.   Also Read: https://www.medgadget.com/2020/06/immunotherapy-drugs-market-size-projection-future-growth-share-value-covid-19-impact-analysis-and-sales-insights-by-2023.html   Some manufactures are tryi...
Read more

Concussions Market By Global Analysis, Research, Review, Applications and Forecast

  Concussions Market – Overview Concussions are among the more frequently caused brain injuries which do not require extensive care or medication. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is on track to touch a CAGR of 3.22% and accumulate revenue worth USD 1,060.4 million at the end of the forecast period. The concussions market has grown in the past few years due to the rising population bases globally. Moreover, individuals are also increasingly engaging in adventure sports and thrill-seeking activities which have drastically increased the incidence of concussions. Also, improvement in concussion management procedures is expected to further incentivize the market growth in the forthcoming forecast period. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/5724 Concussions Market Segmental Analy...
Read more

Gold Nanoparticles Market in Americas Including Top Key Players, Trends And Emerging Growth Factors

Gold nanoparticles (AuNPs) have applications in drug delivery, sensory probes, therapeutic agents, and photovoltaics due to its optoelectronic properties. They are used in conjunction with ionizing and non-ionizing radiation for eliminating cancer tumors. The Americas gold nanoparticles market report by Market Research Future (MRFR) focuses on the types of nanoparticles as well as their applications in thorough detail. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/1129 Market Outlook The Americas gold nanoparticles market size can expand at 16.5% CAGR from 2017 to 2023 (forecast period). The application of these particles for sensing selective biomolecules in the body can drive the market demand. Increasing adoption of nanotechnology in the healthcare sector coupled with rising prevalence of cancer and other chronic diseases can fuel the market demand over the forecast period. According to the Center for Disease Control & Prevention (CDC), c...
Read more